High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry

Aranda, E.B.; Mariño, Zoe; Calvo, S.; Carrión, J.A.; Fernández, I.; García-Samaniego, J.; Baliellas, Carme; Pascasio, J.M.; Albillos, A.; Carrillo, C.F.; Castro-Iglesias, Ángeles; Planas, J.M.M.; Giner, C.P.; Palomares, J.J.M.; Llaneras, J.; Arenas, Juan; Fernández-Bermejo, M.; Fernández, C.; López, R.M.G.; García, P.B.; Romero-Gómez, Manuel; Sáez-Royuela, F.

Ver/abrir

Aranda_THU275.pdf (140.0Kb)

Use este enlace para citar

http://hdl.handle.net/2183/21636

A non ser que se indique outra cousa, a licenza do ítem descríbese como Atribución-NoComercial-SinDerivadas 4.0

Coleccións

Investigación (FCS) [1293]

Metadatos

Mostrar o rexistro completo do ítem

Título

High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry

Data

2017

Cita bibliográfica

Aranda EB, Mariño Z, Calvo S, et al. High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry. En: Abstract of The International Liver Congress, 52nd Annual Meeting of the European Association for the Study of the Liver; 2017 Abr 19-23; Amsterdam. Amsterdam: Elsevier; 2017. p. S311 (Journal of Hepatology. 2017; 66 Suppl 1)